Cohen & Steers, Inc. (New York Stock Exchange:CNS)
| Market Cap | 3.88B+12.1% |
| Revenue (ttm) | 599.09M+5.9% |
| Net Income | 168.30M+3.8% |
| EPS | 3.26+3.5% |
| Shares Out | 51.41M |
| PE Ratio | 23.07 |
| Forward PE | 19.10 |
| Dividend | $2.63(3.49%) |
| Ex-Dividend Date | Aug 10, 2026 |
| Volume | 393,729 |
| Open | 74.71 |
| Previous Close | 74.54 |
| Day's Range | 74.38 - 76.34 |
| 52-Week Range | 58.39 - 86.56 |
| Beta | 1.20 |
| Analysts | Sell |
| Price Target | 88.00(+16.65%) |
| Earnings Date | Oct 15, 2026 |
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About CNS
Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities. Additionally, these subsidiaries develop and oversee a diverse range of investment vehicles, including mutual funds (focused on equity, fixed income, balanced, and multi-asset classes) and hedge funds. The company's global investment strategy, implemented via its affiliated entities, involves allocating capital in public equity, fixed income, and commodity markets. For its equity and fixed income allocations, the firm's affiliates specifically target businesses within the real estate industry (including REITs), infrastructure, and natural energy resources. Preferred securities also constitute a part of its fixed income portfolios. Established in 1986, Cohen & Steers, Inc. maintains its primary base in New York, with international branch offices in London (UK), Central (Hong Kong), Tokyo (Japan), and Seattle (Washington).
$CNS stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of CNS by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 30, 2025 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 29, 2025 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Nov 13, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Nov 12, 2020 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Dec 12, 2019 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Dec 11, 2019 |
Recently reported changes in CNS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CNS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CNS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CNS Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Open-end funds | $88.94M | 58.24% |
| Institutional accounts | $35.75M | 23.41% |
| Closed-end funds | $28.04M | 18.36% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CNS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CNS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CNS
| ETF | Est. Holding Size |
|---|---|
| GABFGabelli Financial Services Opportunities ETF | $248.68M |
| VTIVanguard Morningstar Total Stock Market ETF | $72.53M |
| SCHDSchwab U.S. Dividend Equity ETF | $59.02M |
| IWMiShares Russell 2000 ETF | $53.80M |
| VBVanguard Morningstar Small-Cap ETF | $52.44M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $30.09M |
Estimated from each fund’s disclosed top holdings × AUM
CNS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CNS’s recent data — informational, not investment advice
